Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SPECGX
FDA Approves Unknown Drug — SPECGX LLC

SPECGX LLC has announced the FDA approval of its Generic ANDA075983, gaining the rights to distribute this unbranded pharmaceutical substance. This cl...

Amneal
FDA Approves TRAMADOL HYDROCHLORIDE — Amneal Pharmaceuticals NY LLC

Amneal Pharmaceuticals NY LLC announced the approval of its ANDA for tramadol hydrochloride oral tablet from the FDA, initiating commercialization of ...

Teva
FDA Approves TRAMADOL HYDROCHLORIDE — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. received FDA approval for generic Tramadol Hydrochloride tablets, a development likely to intensify generic competition...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS INC

SUN PHAR INDS INC announced its approval of ANDA075964 on June 19, 2002, but the absence of both brand and generic names alongside the route of admini...

Roerig
FDA Approves VFEND — Roerig

# FDA Approves Roerig's VFEND (voriconazole) for Invasive Fungal Infections Roerig has received FDA approval for VFEND (voriconazole), an oral antifu...

Pfizer
FDA Approves ZITHROMAX — Pfizer Laboratories Div Pfizer Inc

On May 24, 2002, Pfizer announced the approval of the oral formulation of AZITHROMYCIN DIHYDRATE for ZITHROMAX, bolstering the company's ready-to-use ...

APOTEX
FDA Approves Unknown Drug — APOTEX

On April 23, 2002, Apotex announced approval for its abbreviated new drug application (ANDA075984), signaling its entry into the pharma market. This r...

PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT

PHARMOBEDIENT received FDA approval for its ANDA on April 22, 2002, position the company to capture market share and increase competition within the r...

Hikma
FDA Approves BUTORPHANOL TARTRATE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. secured FDA approval for its generic nasal butorphanol tartrate product, reinforcing its strategic expansion within the...

Lannett
FDA Approves LEVOTHYROXINE SODIUM — Lannett Company, Inc

Lannett Company, Inc. leverages the regulatory milestone for its oral levothyroxine sodium formulation to secure a consistent market footprint in the ...

SUN
FDA Approves Unknown Drug — SUN PHARM INDUSTRIES

On February 21, 2002, Sun Pharm Industries announced the approval of generic drug application ANDA076038, subjecting the prescription to generic compe...

REGCON
FDA Approves Unknown Drug — REGCON HOLDINGS

REGCON HOLDINGS announced the FDA approval of ANDA075807, a generic bid that expands its competitive footprint following a 2002 issuance. This regulat...

WATSON
FDA Approves Unknown Drug — WATSON LABS FLORIDA

Watson Pharmaceuticals (now Actavis) received final approval from the U.S. FDA for Abbreviated New Drug Application (ANDA) 075961 on January 25, 2002....

PuraCap
FDA Approves METFORMIN HYDROCHLORIDE — PuraCap Laboratories LLC dba Blu Pharmaceuticals

PuraCap Laboratories LLC dba Blu Pharmaceuticals announced Wednesday the approval of its ANDA for Metformin Hydrochloride, a generic oral drug. This d...

Mylan
FDA Approves METFORMIN HYDROCHLORIDE — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. announced the approval of its Abbreviated New Drug Application for metformin hydrochloride, further strengthening the compa...

HERITAGE
FDA Approves Unknown Drug — HERITAGE PHARMA

On January 25, 2002, Heritage Pharma received FDA approval for NDA 075978, marking the agency's authorization of a new drug. Market implications stem ...

WATSON
FDA Approves Unknown Drug — WATSON LABS

Watson Labs has secured FDA approval for its ANDA 075979, granting launch rights for an unspecified generic formulation made essential market inroads ...

Lifsa
FDA Approves METFORMIN HYDROCHLORIDE — Lifsa Drugs, LLC

The FDA has granted approval for Lifsa Drugs, LLC’s Abbreviated New Drug Application for Metformin Hydrochloride, potentially expanding generic supply...

URONOVA
FDA Approves VABRINTY — URONOVA PHARMACEUTICALS, INC.

# FDA Approves VABRINTY (Leuprolide Acetate) for Subcutaneous Administration Uronova Pharmaceuticals, Inc. received FDA approval for VABRINTY (leupro...

Meridian
FDA Approves ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Meridian Medical Technologies, LLC

Meridian Medical Technologies received updated FDA approval for the market launch of the atropine and pralidoxime chloride auto-injector, a critical a...